Status:
COMPLETED
Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function
Lead Sponsor:
Bayer
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have been done on the efficacy of the herbal medicine Iberogast. In this study researcher want to learn more about the time needed for Iberogast to start to work after the patient took...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- At the discretion of physician under the instructions of Rome III criteria concerning functional gastrointestinal symptoms as well as the summary of product characteristics of Iberogast
- Exclusion criteria:
- Therapeutic necessity
Exclusion
Key Trial Info
Start Date :
June 17 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2011
Estimated Enrollment :
272 Patients enrolled
Trial Details
Trial ID
NCT04059783
Start Date
June 17 2008
End Date
February 20 2011
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, Germany